LOAMU
ARRY

Lombard Odier Asset Management (USA)’s Array Biopharma Inc ARRY Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50,000
Closed -$2.32M – 344
2019
Q2 		$2.32M Buy
+50,000
New +$1.4M 0.19% 123

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s ARRY Position: Q3 2019 in Review

Lombard Odier Asset Management (USA) sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 50,000 shares — an estimated $2.32M sold.

Lombard Odier Asset Management (USA) first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $2.32M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Lombard Odier Asset Management (USA) reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 50,000 Array Biopharma Inc shares in Q3 2019, an estimated $2.32M.
  • Lombard Odier Asset Management (USA) first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Lombard Odier Asset Management (USA)'s Array Biopharma Inc position peaked at $2.32M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2019, filed 14 Nov 2019.